Navigation Links
Novartis Class Awarded $250 Million in Punitive Damages
Date:5/19/2010

trying to earn an honest living. But when corporations do discriminate, this jury's verdict proves that enforcing equal employment rights in the court works. Bad employers beware!"

Judge Colleen McMahon now has the opportunity to order Novartis to change its policies and procedures to prevent future discriminatory behavior. Judge McMahon also will award backpay to the entire class at a later date to make up for the lost earnings Novartis wrongfully denied its female employees. 

Significantly, in separate proceedings, compensatory damages also will be decided for each member of the class that opts-in, to include monetary damages for the pain and suffering caused by Novartis' discriminatory acts. 

The class includes female sales representatives who worked for the drug giant between 2002 and 2007.  Thirteen of them testified during the five-week trial in the class action originally filed in 2004 (Amy Velez et al., vs. Novartis Pharmaceuticals Corporation 04 Civ. 09194.)

Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz pharmaceutical companies. Headquartered in Basel, Switzerland, the company had 2009 sales of $44.3 billion.

Sanford Wittels & Heisler is a law firm with offices in Washington, D.C., New York, and San Francisco that specializes in employment discrimination, wage and hour, consumer and complex corporate class action litigation and has represented thousands of individuals in some of the major class action cases in the United States. The firm also represents individual clients i
'/>"/>

SOURCE Sanford Wittels & Heisler LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
2. Oral Drug From Novartis/Mitsubishi Tanabe Will Capture the Largest Market Share of All Emerging Multiple Sclerosis Therapies in 2017
3. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
4. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
5. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
6. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
7. Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US
8. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
9. Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
10. Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
11. Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR(TM) Technology and Generate Novel Drug Leads Against a GPCR Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 Neurotrope, ... host a conference call to provide an update ... p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. and ... Live web cast: www.neurotropebioscience.com , under "Investor Relations"The ... after completion through September 2, 2014 at (888) ...
(Date:8/20/2014)... Toronto, Canada (PRWEB) August 20, 2014 ... wisdom that E&L studies should be performed late in ... system is known. But current regulatory trends suggest that, ... are on the rise. In recent years, multiple drug ... E&L packages or address specific questions during phase I/II. ...
(Date:8/19/2014)... (PRWEB) August 20, 2014 One ... regenerative medicine is an inadequate vascular supply. Nutrient ... and decellularized tissues is critical for successful regeneration ... attempted to mitigate deficiencies in vascularization and promote ... scaffold bioactivity, optimizing scaffold design and architecture, and ...
(Date:8/19/2014)... , Aug. 19, 2014 Research and ... Fuel Cells (SOFCs) - Global Strategic Business Report" report ... worldwide markets for Solid Oxide Fuel Cells (SOFCs) in US$ ... Canada , Europe , ... estimates and forecasts are provided for the period 2012 through ...
Breaking Biology Technology:Neurotrope To Host Conference Call 2Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2
... Tectonics Corporation,s (Amex: ETC ) ("ETC" or ... of two BARA-MED(R)XD Monoplace hyperbaric oxygen chambers in the ... state-of-the-art monoplace chambers are the first computer-controlled hyperbaric chambers ... , Hyperbaric oxygen (HBO) ...
... REYKJAVIK, Iceland, Dec. 8 deCODE genetics,(Nasdaq: ... an international consortium of,scientists from deCODE and major ... variation in the human genome (SNP) that is ... type 2 diabetes (T2D). deCODE,will employ its CLIA-registered ...
... NVAX ) today announced that the Company will hold ... human clinical trial in,healthy adult subjects of Novavax,s seasonal influenza ... 2008. , The call ... Rahul Singhvi and other members of senior management, including Chief,Medical ...
Cached Biology Technology:Environmental Tectonics Corporation Announces Placement of Two Monoplace Chambers at St. John Wound Center; First Computer-controlled Hyperbaric Chambers in Oklahoma 2Environmental Tectonics Corporation Announces Placement of Two Monoplace Chambers at St. John Wound Center; First Computer-controlled Hyperbaric Chambers in Oklahoma 3Environmental Tectonics Corporation Announces Placement of Two Monoplace Chambers at St. John Wound Center; First Computer-controlled Hyperbaric Chambers in Oklahoma 4deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service 2deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service 3deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service 4Novavax to Present Seasonal Influenza Data Results in an Investor Conference Call on December 11, 2008 2
(Date:8/21/2014)... of radiations in the 3.3 to 4.4 nanometre range, ... tissues. New theoretical findings show that it is possible ... could be the basis of an optimal technique to ... to be used in high-precision spectroscopy. Now, a new ... generate the harmonic radiationswhich are multiples of an incoming ...
(Date:8/21/2014)... successfully replicated one of the crucial steps in photosynthesis, ... which could manufacture hydrogen as a fuel. , "Water ... exciting prospect to use them to create hydrogen, and ... from the ARC Centre of Excellence for Translational Photosynthesis ... offers potential as a zero-carbon replacement for petroleum products, ...
(Date:8/20/2014)... Huntsman Cancer Institute (HCI) at the University of Utah ... that encodes BCR-ABL, the unregulated enzyme driving the blood ... Cancer Society, nearly 6,000 new cases of CML will ... called tyrosine kinase inhibitors (TKIs), target BCR-ABL and are ... CML but control it in a way that allows ...
Breaking Biology News(10 mins):Water window imaging opportunity 2Water and sunlight the formula for sustainable fuel 2Blueprint for next generation of chronic myeloid leukemia treatment 2
... cousin of the humble mustard plant, scientists at the ... big surprise while investigating how plants respond to attacks ... "Contrary to what we thought we'd find, our experiments ... concert with one another in tug-of war or teeter ...
... statistical method is a more reliable way to map ... potential cancer treatment targets, according to new Brown University ... a promising new tool for tracing human gene connections, ... other diseases. Results appeared this week in the online ...
... the humble mustard plant, scientists at the University of ... while investigating how plants respond to attacks from disease ... what we thought we'd find, our experiments showed that ... one another in tug-of war or teeter totter-fashion to ...
Cached Biology News:FDA approves more generic AIDS drugs 2FDA approves more generic AIDS drugs 3Researchers develop promising new gene network analysis method 2UNC plant researchers discover proteins interact to form hair-trigger protection against invaders 2UNC plant researchers discover proteins interact to form hair-trigger protection against invaders 3
Pancreatic Cell Cryopreservation Medium (2X) is intended for the cryopreservation of LT2 Immortalized Pancreatic Mesenchymal Cells (SCR013) and VIT1 Primary Pancreatic Mesenchymal Cells (SCR014)....
LAB/Probe Mouse-Rabbit DAB Kit...
Mouse monoclonal [SH-A1] to S100 alpha ( Abpromise for all tested applications). entrezGeneID: 6271 SwissProtID: P23297...
G-protein coupled purinergic receptor P2Y8...
Biology Products: